Antiverse is a Cardiff, United Kingdom–based biotech company that designs and discovers antibodies using machine learning to tackle challenging drug targets. Their technology aims to move from target identification to functional antibody within about six months, focusing on targets such as GPCRs and ion channels. They combine computational design with state-of-the-art laboratory screening and multiparameter clustering to generate lead candidates with desirable properties. The company emphasizes partnerships with pharmaceutical companies and global drug discovery programs.
No recent news for this company.